Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 28, 2017
Boston Scientific will participate in the Morgan Stanley healthcare conference on Sept. 12, 2017. Learn how to watch the webcast or replay.
-
Aug 21, 2017
Boston Scientific will participate in the healthcare conference on September 7, 2017. Learn how to watch the webcast or replay.
-
Jul 31, 2017
Boston Scientific will participate in the investor conference on August 9, 2017. Learn how to watch the webcast or replay.
-
Jul 27, 2017
"Our strong financial performance in the first half of 2017 reflects our innovative portfolio,” said CEO Mike Mahoney.
-
Jul 5, 2017
Boston Scientific will webcast its conference call with financial results for Q2 ended June 30, 2017. Learn how to tune in or watch the replay.
-
Jun 27, 2017
Investor meeting will cover Boston Scientific’s business and long-term growth strategies, including by expanding category leadership and driving global growth.
-
Jun 6, 2017Industry's First MR-Conditional Directional DBS System with Stimulation Visualization
Industry's first MR-conditional directional DBS System with stimulation visualization
-
May 24, 2017Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference
Results from evaluation of real-world patients presented at American Thoracic Society International Conference
-
May 17, 2017
Boston Scientific will participate in the healthcare conference on May 23, 2017. Learn how to watch the webcast or replay.
-
May 16, 2017
The first head-to-head pivotal study comparing two different TAVI platforms demonstrated the LOTUS™ Valve System’s superior efficacy.
-
May 16, 2017Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease
BAcquisition expands company's structural heart portfolio; increases offerings for the treatment of patients with valvular heart disease
-
May 12, 2017Largest Prospective Study of the WATCHMAN Device Presented as Late-Breaking Trial at Heart Rhythm 2017
Largest prospective study of the WATCHMAN device presented as late-breaking trial at Heart Rhythm 2017
-
May 12, 2017Analyses Evaluated the Impact of Ethnicity, Gender and Income on Cardiovascular Outcomes
Analyses evaluated the impact of ethnicity, gender and income on cardiovascular outcomes
-
May 11, 2017Late-Breaker Data Presented at Heart Rhythm 2017
Late-breaker data presented at Heart Rhythm 2017
-
May 10, 2017Pivotal Data from REPRISE III and EWOLUTION Among Four Late-breaking Clinical Trials to be Presented
Pivotal data from REPRISE III and EWOLUTION among four late-breaking clinical trials to be presented
-
May 9, 2017New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
New devices combine longest-lasting battery technology, therapy optimization and HeartLogic™ heart failure diagnostics
-
May 3, 2017Late-Breaking Clinical Trials Feature Subcutaneous Implantable Defibrillator and WATCHMAN™ Left Atrial Appendage Closure Device
Late-breaking clinical trials feature subcutaneous implantable defibrillator (S-ICD) and WATCHMAN™ left atrial appendage closure device
-
May 1, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2017 Healthcare Conference on Thursday, May 18, 2017 in Las Vegas. Susie Lisa, vice...
-
Apr 27, 2017
"We are pleased with our performance in the first quarter,” said CEO Mike Mahoney
-
Apr 18, 2017MADIT S-ICD Trial to Study EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System; Trial Recruitment Part of Pilot Initiative to Increase Percentage of Females Enrolled in Clinical Studies
MADIT S-ICD trial to study EMBLEM™ MRI S-ICD System; part of pilot initiative to increase percentage of females enrolled in clinical studies
-
Mar 30, 2017
Boston Scientific will webcast both its Investor Day meeting and its conference call with financial results for Q1 ended March 31, 2017. Learn how to tune in.
-
Mar 30, 2017Acquisition Will Expand Treatments for Patients with Valvular Heart Disease and Strengthen Company's Position in Structural Heart Globally
Acquisition will expand treatments for patients with valvular heart disease and strengthen company's position in structural heart globally
-
Mar 16, 2017Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; has potential for significant cost savings
Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; potential for significant cost savings
-
Mar 9, 2017Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.
Edwards found to infringe on Boston Scientific patents in Germany and U.K.
-
Mar 7, 2017
Boston Scientific will participate in the healthcare conference on March 15, 2017. A live webcast and replay will be available.